[go: up one dir, main page]

AR087879A1 - Composiciones para el tratamiento de ulceras perifericas de diversos origenes - Google Patents

Composiciones para el tratamiento de ulceras perifericas de diversos origenes

Info

Publication number
AR087879A1
AR087879A1 ARP120103397A ARP120103397A AR087879A1 AR 087879 A1 AR087879 A1 AR 087879A1 AR P120103397 A ARP120103397 A AR P120103397A AR P120103397 A ARP120103397 A AR P120103397A AR 087879 A1 AR087879 A1 AR 087879A1
Authority
AR
Argentina
Prior art keywords
compositions
treatment
extracts
ulceras
peripheral
Prior art date
Application number
ARP120103397A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of AR087879A1 publication Critical patent/AR087879A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Composiciones que comprenden: a) aditivos de bisulfito de antocianósidos o extractos que los contengan, b) extracto lipofílico de Echinacea sp. y opcionalmente c) visnadinea y/o esculosida. Reivindicación 2: Las composiciones de acuerdo con la reivindicación 1, donde los extractos con contenido de antocianósidos son extractos de Vaccinium myrtillus, Vitis vinifera, Sambucus nigra o Ribes nigrum. Reivindicación 3: Las composiciones de acuerdo con la reivindicación 1, donde los extractos con contenido de antocianósidos son extractos de Ericaceae, preferentemente de Vaccinium sp. Reivindicación 10: Aditivos de bisulfito de antocianósidos puros o extractos que los contengan para su empleo como medicamentos tópicos para el tratamiento de úlceras y heridas.
ARP120103397A 2011-09-16 2012-09-14 Composiciones para el tratamiento de ulceras perifericas de diversos origenes AR087879A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001671A ITMI20111671A1 (it) 2011-09-16 2011-09-16 Composizioni per il trattamento di ulcere periferiche di varia origine

Publications (1)

Publication Number Publication Date
AR087879A1 true AR087879A1 (es) 2014-04-23

Family

ID=44907960

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103397A AR087879A1 (es) 2011-09-16 2012-09-14 Composiciones para el tratamiento de ulceras perifericas de diversos origenes

Country Status (21)

Country Link
US (3) US9278084B2 (es)
EP (1) EP2755670B1 (es)
JP (1) JP6026540B2 (es)
KR (1) KR101996319B1 (es)
CN (1) CN103874499B9 (es)
AR (1) AR087879A1 (es)
AU (1) AU2012307406B2 (es)
BR (1) BR112014005966A2 (es)
CA (1) CA2848570C (es)
DK (1) DK2755670T3 (es)
ES (1) ES2577405T3 (es)
HU (1) HUE028120T2 (es)
IL (1) IL231498B (es)
IT (1) ITMI20111671A1 (es)
MX (1) MX347245B (es)
PL (1) PL2755670T3 (es)
PT (1) PT2755670E (es)
RU (1) RU2619853C2 (es)
SG (1) SG11201400617UA (es)
SI (1) SI2755670T1 (es)
WO (1) WO2013037859A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201690021A1 (ru) * 2013-07-14 2016-08-31 Асирос А/С Алкалоидные композиции из вида ribes для лечения состояний, связанных с функцией митохондрий или ингибированием pde4, pde5 и ikk-бета
CN103961482A (zh) * 2014-04-23 2014-08-06 湖州康企药业有限公司 一种治疗皮炎的天然药物
ITUB20160672A1 (it) * 2016-02-11 2017-08-11 Mireno Leoni Composizione farmaceutica per il trattamento della disidrosi
KR101892865B1 (ko) 2017-08-16 2018-08-28 계명대학교 산학협력단 마퀴베리를 유효성분으로 함유하는 아토피성 피부염 예방 또는 치료용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
US4376781A (en) * 1978-02-27 1983-03-15 Inverni Della Beffa S.P.A. Pharmaceutical compositions
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
IT1255029B (it) * 1992-05-11 1995-10-13 Paolo Morazzoni Formulazioni farmaceutiche orali contenenti antocianosidi
IT1270602B (it) * 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
CA2421109C (en) * 2000-08-31 2011-05-03 Hauser, Inc. Efficient method for producing compositions enriched in anthocyanins
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
US20030152610A1 (en) * 2002-01-28 2003-08-14 David Rolf Cosmetic patch
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
RU2203082C1 (ru) * 2002-07-22 2003-04-27 Государственное учреждение Тверская государственная медицинская академия Способ лечения язвенно-эрозивных поражений гастродуоденальной зоны в сочетании с артериальной гипертензией
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
TWI286941B (en) * 2005-07-27 2007-09-21 Anagen Therapeutics Inc Stabilized pharmaceutical and cosmetic composition of catechins or derivatives thereof
GB2428952B (en) 2005-07-30 2010-10-06 Hewlett Packard Development Co Digital pen and paper system
US7763289B2 (en) * 2005-09-01 2010-07-27 JoAl's Products, LLC Topical turmeric skin care products
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
WO2010011541A2 (en) * 2008-07-22 2010-01-28 Izun Pharmaceuticals, Inc. Topical anti-inflammatory combination

Also Published As

Publication number Publication date
US20170035826A1 (en) 2017-02-09
SG11201400617UA (en) 2014-05-29
CA2848570C (en) 2020-12-22
CN103874499A (zh) 2014-06-18
IL231498A0 (en) 2014-04-30
WO2013037859A1 (en) 2013-03-21
KR101996319B1 (ko) 2019-07-04
IL231498B (en) 2018-01-31
US20160058812A1 (en) 2016-03-03
SI2755670T1 (sl) 2016-07-29
PL2755670T3 (pl) 2016-11-30
US9278084B2 (en) 2016-03-08
KR20140067045A (ko) 2014-06-03
US20140220165A1 (en) 2014-08-07
PT2755670E (pt) 2016-06-20
US10149877B2 (en) 2018-12-11
RU2619853C2 (ru) 2017-05-18
EP2755670B1 (en) 2016-05-11
CA2848570A1 (en) 2013-03-21
CN103874499B9 (zh) 2018-09-21
JP2014526487A (ja) 2014-10-06
AU2012307406A1 (en) 2014-04-03
BR112014005966A2 (pt) 2017-04-04
JP6026540B2 (ja) 2016-11-16
ITMI20111671A1 (it) 2013-03-17
HUE028120T2 (en) 2016-11-28
RU2014109796A (ru) 2015-09-20
AU2012307406B2 (en) 2016-11-17
ES2577405T3 (es) 2016-07-14
US9526716B2 (en) 2016-12-27
CN103874499B (zh) 2018-07-27
MX347245B (es) 2017-04-19
DK2755670T3 (en) 2016-08-15
EP2755670A1 (en) 2014-07-23
MX2014003051A (es) 2014-04-10

Similar Documents

Publication Publication Date Title
CO6280445A2 (es) Composicion que comprende un cladosporium y un portador para las esporas
AR086398A1 (es) Canabinoides que pueden usarse en el tratamiento del dolor neuropatico
MX386820B (es) Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología.
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CO6710926A2 (es) Compuestos de n-heteroarilo
HN2010002518A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
PE20142367A1 (es) Formulaciones de imiquimod
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
MX348064B (es) Imidazopiridazinas sustituidas con amino.
UY35652A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
MX2009007389A (es) Composiciones paras el cuidado oral que comprende extracto de hippophae.
PE20121700A1 (es) Composicion que comprende l-carnitina o propionil l-carnitina, troxerutina, diosmina y hesperidina
AR087879A1 (es) Composiciones para el tratamiento de ulceras perifericas de diversos origenes
AR083594A1 (es) Composiciones para el tratamiento de ulceras perifericas de varios origenes
MX2016005359A (es) Composicion para usarse en el tratamiento de la tos.
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
AR076520A1 (es) Parasiticidas sanguineos. composicion
PE20141128A1 (es) Composiciones para la detersion, granulacion y re-epitelizacion de heridas en humanos
MX2021000282A (es) Composicion que contiene un 7beta-hidroxicolesterol y un vehiculo de lipido, y su uso en el tratamiento de patologias neoplasicas.
MX2016003650A (es) Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica.
CR20150641U (es) Composiciones farmacéuticas
CL2012003280A1 (es) Compuestos derivados de piperidina; composición farmacéutica que los comprende; y su uso para tratar o mejorar patologías tau o amiloide, tales como la enfermedad de alzheimer, o síntomas de las mismas.
ES2570531T3 (es) Nuevas composiciones para el tratamiento de las úlceras crónicas
DOP2009000093A (es) Dihidropirazolonas sustituídas para el tratamiento de enfermedades cardiovasculares y hematológicas

Legal Events

Date Code Title Description
FB Suspension of granting procedure